Author: Spagnolello, Ornella; Pinacchio, Claudia; Santinelli, Letizia; Vassalini, Paolo; Innocenti, Giuseppe Pietro; De Girolamo, Gabriella; Fabris, Silvia; Giovanetti, Marta; Angeletti, Silvia; Russo, Alessandro; Mastroianni, Claudio M.; Ciccozzi, Massimo; Ceccarelli, Giancarlo; d'Ettorre, Gabriella
Title: Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection Cord-id: bjv21q29 Document date: 2021_3_23
ID: bjv21q29
Snippet: Respiratory and gastrointestinal symptoms are the predominant clinical manifestations of the coronavirus disease 2019 (COVID-19). Infecting intestinal epithelial cells, the severe acute respiratory syndrome coronavirus-2 may impact on host's microbiota and gut inflammation. It is well established that an imbalanced intestinal microbiome can affect pulmonary function, modulating the host immune response (“gut-lung axisâ€). While effective vaccines and targeted drugs are being tested, alternati
Document: Respiratory and gastrointestinal symptoms are the predominant clinical manifestations of the coronavirus disease 2019 (COVID-19). Infecting intestinal epithelial cells, the severe acute respiratory syndrome coronavirus-2 may impact on host's microbiota and gut inflammation. It is well established that an imbalanced intestinal microbiome can affect pulmonary function, modulating the host immune response (“gut-lung axisâ€). While effective vaccines and targeted drugs are being tested, alternative pathophysiology-based options to prevent and treat COVID-19 infection must be considered on top of the limited evidence-based therapy currently available. Addressing intestinal dysbiosis with a probiotic supplement may, therefore, be a sensible option to be evaluated, in addition to current best available medical treatments. Herein, we summed up pathophysiologic assumptions and current evidence regarding bacteriotherapy administration in preventing and treating COVID-19 pneumonia.
Search related documents:
Co phrase search for related documents- ace enzyme and active site: 1, 2, 3, 4, 5, 6, 7, 8, 9
- ace enzyme and activity number: 1
- ace enzyme and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ace enzyme and acute lung injury prevent: 1
- ace enzyme and acute phase: 1, 2, 3, 4, 5
- ace enzyme and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ace enzyme and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ace enzyme inhibit and acute respiratory syndrome: 1
- ace inhibitor and active site: 1, 2
- ace inhibitor and acute lung injury: 1, 2, 3, 4
- ace inhibitor and acute phase: 1
- ace inhibitor and acute respiratory distress syndrome: 1, 2, 3, 4, 5
- ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acid bacteria and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
- active site and acute lung injury: 1, 2
- active site and acute respiratory distress syndrome: 1, 2
- active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- activity number and acute respiratory distress syndrome: 1, 2, 3, 4
- activity number and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
Co phrase search for related documents, hyperlinks ordered by date